SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-16-559181
Filing Date
2016-04-27
Accepted
2016-04-27 15:31:08
Documents
5
Effectiveness Date
2016-04-27

Document Format Files

Seq Description Document Type Size
1 DEFA14A d49424ddefa14a.htm DEFA14A 17472
2 GRAPHIC g494241.jpg GRAPHIC 115128
3 GRAPHIC g494242.jpg GRAPHIC 202801
4 GRAPHIC g494243.jpg GRAPHIC 58365
5 GRAPHIC g494244.jpg GRAPHIC 10918
  Complete submission text file 0001193125-16-559181.txt   536667
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35347 | Film No.: 161595033
SIC: 2834 Pharmaceutical Preparations